These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
921 related items for PubMed ID: 12876289
1. Insulin-like growth factor-I inhibits transcriptional responses of transforming growth factor-beta by phosphatidylinositol 3-kinase/Akt-dependent suppression of the activation of Smad3 but not Smad2. Song K, Cornelius SC, Reiss M, Danielpour D. J Biol Chem; 2003 Oct 03; 278(40):38342-51. PubMed ID: 12876289 [Abstract] [Full Text] [Related]
2. The phosphatidylinositol 3-kinase/Akt pathway enhances Smad3-stimulated mesangial cell collagen I expression in response to transforming growth factor-beta1. Runyan CE, Schnaper HW, Poncelet AC. J Biol Chem; 2004 Jan 23; 279(4):2632-9. PubMed ID: 14610066 [Abstract] [Full Text] [Related]
3. Critical role of a survivin/TGF-β/mTORC1 axis in IGF-I-mediated growth of prostate epithelial cells. Song K, Shankar E, Yang J, Bane KL, Wahdan-Alaswad R, Danielpour D. PLoS One; 2013 Jan 23; 8(5):e61896. PubMed ID: 23658701 [Abstract] [Full Text] [Related]
4. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells. Poncelet AC, de Caestecker MP, Schnaper HW. Kidney Int; 1999 Oct 23; 56(4):1354-65. PubMed ID: 10504488 [Abstract] [Full Text] [Related]
5. The androgen receptor represses transforming growth factor-beta signaling through interaction with Smad3. Chipuk JE, Cornelius SC, Pultz NJ, Jorgensen JS, Bonham MJ, Kim SJ, Danielpour D. J Biol Chem; 2002 Jan 11; 277(2):1240-8. PubMed ID: 11707452 [Abstract] [Full Text] [Related]
9. IGF-binding proteins mediate TGF-beta 1-induced apoptosis in bovine mammary epithelial BME-UV1 cells. Gajewska M, Motyl T. Comp Biochem Physiol C Toxicol Pharmacol; 2004 Oct 11; 139(1-3):65-75. PubMed ID: 15556067 [Abstract] [Full Text] [Related]
10. Loss of phosphatase and tensin homologue increases transforming growth factor beta-mediated invasion with enhanced SMAD3 transcriptional activity. Hjelmeland AB, Hjelmeland MD, Shi Q, Hart JL, Bigner DD, Wang XF, Kontos CD, Rich JN. Cancer Res; 2005 Dec 15; 65(24):11276-81. PubMed ID: 16357132 [Abstract] [Full Text] [Related]
11. Dual regulation of MMP-2 expression by the type 1 insulin-like growth factor receptor: the phosphatidylinositol 3-kinase/Akt and Raf/ERK pathways transmit opposing signals. Zhang D, Bar-Eli M, Meloche S, Brodt P. J Biol Chem; 2004 May 07; 279(19):19683-90. PubMed ID: 14993222 [Abstract] [Full Text] [Related]
12. Transforming growth factor-beta inhibition of insulin-like growth factor-binding protein-5 synthesis in skeletal muscle cells involves a c-Jun N-terminal kinase-dependent pathway. Rousse S, Lallemand F, Montarras D, Pinset C, Mazars A, Prunier C, Atfi A, Dubois C. J Biol Chem; 2001 Dec 14; 276(50):46961-7. PubMed ID: 11598109 [Abstract] [Full Text] [Related]
13. Insulin-like growth factor-1 regulates endogenous RUNX2 activity in endothelial cells through a phosphatidylinositol 3-kinase/ERK-dependent and Akt-independent signaling pathway. Qiao M, Shapiro P, Kumar R, Passaniti A. J Biol Chem; 2004 Oct 08; 279(41):42709-18. PubMed ID: 15304489 [Abstract] [Full Text] [Related]
14. Activated phosphatidylinositol 3-kinase/Akt inhibits the transition of endothelial progenitor cells to mesenchymal cells by regulating the forkhead box subgroup O-3a signaling. Zhang Z, Zhang T, Zhou Y, Wei X, Zhu J, Zhang J, Wang C. Cell Physiol Biochem; 2015 Oct 08; 35(4):1643-53. PubMed ID: 25824462 [Abstract] [Full Text] [Related]
15. Insulin-like growth factor-1-induced phosphorylation of the forkhead family transcription factor FKHRL1 is mediated by Akt kinase in PC12 cells. Zheng WH, Kar S, Quirion R. J Biol Chem; 2000 Dec 15; 275(50):39152-8. PubMed ID: 10995739 [Abstract] [Full Text] [Related]
16. Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer. Cui X, Zhang P, Deng W, Oesterreich S, Lu Y, Mills GB, Lee AV. Mol Endocrinol; 2003 Apr 15; 17(4):575-88. PubMed ID: 12554765 [Abstract] [Full Text] [Related]
17. Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/mammalian target of rapamycin signaling pathway and activation of hypoxia inducible factor-1alpha. Phillips RJ, Mestas J, Gharaee-Kermani M, Burdick MD, Sica A, Belperio JA, Keane MP, Strieter RM. J Biol Chem; 2005 Jun 10; 280(23):22473-81. PubMed ID: 15802268 [Abstract] [Full Text] [Related]
18. The murine gastrin promoter is synergistically activated by transforming growth factor-beta/Smad and Wnt signaling pathways. Lei S, Dubeykovskiy A, Chakladar A, Wojtukiewicz L, Wang TC. J Biol Chem; 2004 Oct 08; 279(41):42492-502. PubMed ID: 15292219 [Abstract] [Full Text] [Related]
19. Insulin-like growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erk1-Erk2 and phosphatidylinositol 3'-kinase-Akt signaling pathways. Thimmaiah KN, Easton J, Huang S, Veverka KA, Germain GS, Harwood FC, Houghton PJ. Cancer Res; 2003 Jan 15; 63(2):364-74. PubMed ID: 12543789 [Abstract] [Full Text] [Related]
20. Sp1 and Smad proteins cooperate to mediate transforming growth factor-beta 1-induced alpha 2(I) collagen expression in human glomerular mesangial cells. Poncelet AC, Schnaper HW. J Biol Chem; 2001 Mar 09; 276(10):6983-92. PubMed ID: 11114293 [Abstract] [Full Text] [Related] Page: [Next] [New Search]